
{{Act of Congress
| congress       = 113
| session        = 1
| title          = To amend part D of title XVIII of the Social Security Act to count the negotiated price of drugs provided free or at nominal charge under compassionate treatment programs towards incurred out-of-pocket costs.
| year           = 2013
| month          = 03
| day            = 18
| bill           = 1239
| billtype       = hr
| purpose        = To amend part D of title XVIII of the Social Security Act to count the negotiated price of drugs provided free or at nominal charge under compassionate treatment programs towards incurred out-of-pocket costs.
}}
113 HR 1239 IH: Accessing Medicare Therapies Act of 2013U.S. House of Representatives2013-03-18text/xmlENPursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
{{Center|113th CONGRESS}}


{{Center|1st Session}}


{{Center|H. R. 1239}}


{{Center|IN THE HOUSE OF REPRESENTATIVES}}


{{Center|March 18, 2013}}


{{Center|
[[w:Bill Cassidy|Mr. Cassidy]] (for himself and
[[w:Doris Matsui|Ms. Matsui]] ) introduced the following bill; which was referred to the [[w:United States House Committee on Energy and Commerce|Committee on Energy and Commerce]] , and in addition to the Committee on [[w:United States House Committee on Ways and Means|Ways and Means]] , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned}}


{{Center|A BILL}}

To amend part D of title XVIII of the Social Security Act to count the negotiated price of drugs provided free or at nominal charge under compassionate treatment programs towards incurred out-of-pocket costs.

={{anchor|H2A5FD40EB37744E881F4E1B1F1BBA130}}Section 1. Short title=

This Act may be cited as the“Accessing Medicare Therapies Act of 2013”.

={{anchor|H2FDD66953C924C298E779F2E04F7AE29}}Sec. 2. Counting the negotiated price of drugs provided free or at nominal charge under compassionate treatment programs towards incurred out-of-pocket costs=



=={{anchor|H7B8F97E140294B6EA9B2F8ED53C11475}}(a) In general– ==

 Section 1860D–2(b)(4) of the Social Security Act([http://www.law.cornell.edu/uscode/text// [http://www.law.cornell.edu/uscode/text/42/1395w–102 42 U.S.C. 1395w–102(b)(4)] ] )is amended—
:(1) in subparagraph (C), by striking“ subparagraph (E)”and inserting“ subparagraphs (E)and (F)”; and
:(2) by adding at the end the following new subparagraph:

<blockquote>

===={{anchor|H0033FE0581294B1EA6EC53D95763303B}}(F) Inclusion of negotiated price of drugs provided under compassionate treatment programs– ====



====={{anchor|H518C83F6BC7D4CFB84C1D5C7183DD765}}(i) In general– =====

In applying subparagraph (A)with respect to an individual enrolled in a prescription drug plan, incurred costs shall include the negotiated price described in clause (ii)of a covered part D drug if—
:(I) the drug is classified, for purposes of applying tiered copayments consistent with section 1860D–2(b)(2)(B), in the highest copayment tier (such as a tier 4 for specialty brand-name drugs);
:(II) the drug is furnished to the individual free or at nominal charge under a compassionate treatment program (as defined in clause (iii)); and
:(III) the drug, if furnished other than through such program, is covered under the formulary of the plan or is available through exception or appeal.

====={{anchor|H3927657E982345C99284A0F8698CAD48}}(ii) Negotiated price– =====

The negotiated price described in this clause, for a covered part D drug which is dispensed to an enrollee—
:(I) by a pharmacy, is the negotiated price at such pharmacy; or
:(II) other than by a pharmacy, is the average negotiated price for the drug in the prescription drug plan in the zip code of the enrollee as of the date the drug is dispensed.

====={{anchor|H7204D1A3FCD2487EAC5EB02D40014A5F}}(iii) Compassionate treatment program defined– =====

In this subparagraph, the term compassionate treatment program means, with respect to covered part D drugs, a program that—
:(I) is administered by an entity described in [http://www.law.cornell.edu/uscode/text// section 501(c)(3)] of the Internal Revenue Code of 1986that is exempt from tax under section 501(a) of such Code;
:(II) takes title to the drugs and distributes the drugs to eligible part D individuals free or at nominal charge on the basis of the entity’s assessment of financial need of such individuals;
:(III) does not distribute the drugs to an individual unless the individual’s household income (as determined under [http://www.law.cornell.edu/uscode/text// section 36B] of the Internal Revenue Code of 1986) is less than the maximum income level for the taxpayer in the household to be eligible for a refundable credit under such section; and
:(IV) meets such additional requirements as the [[w:|Inspector General of the Department of Health and Human Services]] establishes, consistent with guidance and advisory opinions issued under section 1128D, to prevent fraud or abuse in the application of this subparagraph..
</blockquote>


=={{anchor|HC1BFC233868644E3AAC16774C88E3CEA}}(b) Effective date– ==

The amendments made by subsection (a)shall apply to drugs furnished in plan years beginning on or after January 1, 2014.